Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
16,5 HKD | +0,98 % | +11,34 % | +18,71 % |
Resumen de negocios
Número de empleados: 3 637
Ventas por actividad
HKD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100,0
%
| 3 738 | 100,0 % | 5 961 | 100,0 % | +59,47 % |
Ventas por región
HKD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
89,2
%
| 3 303 | 88,4 % | 5 316 | 89,2 % | +60,92 % |
North America
5,8
%
| 169 | 4,5 % | 348 | 5,8 % | +106,21 % |
Asia Pacific (excluding China)
3,6
%
| 208 | 5,6 % | 214 | 3,6 % | +3,00 % |
Europe
1,0
%
| 58 | 1,6 % | 62 | 1,0 % | +6,83 % |
South America
0,4
%
| - | - | 21 | 0,4 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Wei Dong Jiang
FOU | Founder | - | 01/12/09 |
Jun Zhu
CEO | Chief Executive Officer | 46 | 30/11/21 |
Wei Huang
PSD | President | 56 | 01/10/20 |
Wen Jie Zhang
CHM | Chairman | 57 | 01/03/19 |
Simon Hsu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Miao Jie Chen
CMP | Compliance Officer | 41 | - |
Ye Xing Yuan
BRD | Director/Board Member | 39 | 01/01/23 |
Jin Li
LAW | General Counsel | - | 13/09/21 |
Jing Li
PRN | Corporate Officer/Principal | - | - |
Ping Cao
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Qi Yu Chen
BRD | Director/Board Member | 52 | 15/01/13 |
Xiao Hui Guan
BRD | Director/Board Member | 53 | 24/12/18 |
Yi Fang Wu
BRD | Director/Board Member | 54 | 12/06/15 |
Rui Lin Song
BRD | Director/Board Member | 61 | 02/09/19 |
De Yong Wen
BRD | Director/Board Member | 52 | 28/07/22 |
Guo Ping Zhao
BRD | Director/Board Member | 75 | 02/09/19 |
Wen Jie Zhang
CHM | Chairman | 57 | 01/03/19 |
Rong Li Feng
CHM | Chairman | 49 | 21/04/20 |
Jun Zhu
CEO | Chief Executive Officer | 46 | 30/11/21 |
Ye Xing Yuan
BRD | Director/Board Member | 39 | 01/01/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 380 066 312 | 0 | 0 | 15,03 % |
Acción B | 1 | 163 428 541 | 81 687 447 ( 49,98 %) | 0 |
Información de la empresa
Shanghai Henlius Biotech, Inc.
Innov Tower 1801 Hongmei Road, Xuhui District
200233, Shanghai
+
http://www.henlius.comVentas por región
Revisiones del BPA
Beneficios anuales - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
+18,71 % | 1145,55 M | |
-4,66 % | 86,13 mil M | |
+1,32 % | 39,82 mil M | |
-19,27 % | 30,42 mil M | |
+57,86 % | 25,23 mil M | |
-17,69 % | 11,6 mil M | |
-43,00 % | 11,51 mil M | |
-9,14 % | 11,95 mil M | |
+5,24 % | 8710,47 M | |
-8,42 % | 8115,21 M |
- Bolsa de valores
- Acciones
- Acción 2696
- Empresa Shanghai Henlius Biotech, Inc.